The renewal application represents years 35 - 40 of the institutional training grant in pulmonary diseases from the University of Colorado Denver. The continuing goal of the program, is to prepare l /ID and PhD trainees for careers in the translational research of lung diseases. The program incorporates a multidisciplinary and interdisciplinary approach highlighting opportunities for either clinical-translational or basic translational T32 trainees. This is accomplished by recruiting exceptional and committed applicants and exposing them to an environment which features dedicated, experienced, and well funded mentors. To adapt to the current research environment and to facilitate cross fertilization, collaboration and the incorporation of new high throughput platforms we have reorganized the research activity into four firms: Injury, Repair, Remodeling;Vascular Biology;Host Defense, Immunology;and Epithelial Cell Biology. The program plan for both MD and PhD trainees includes oversight by the PD/PI, a programmatic research oversight committee, individual trainee research committees, and trainee mentor(s) in the School of Public Health and the Clinical Science Program of the CTSA. There are also postgraduate degree programs for clinical-translational research trainees (MPH, PhD) and advanced course work for basic translational researchers. The trainees are made aware of their responsibilities when accepting a T32 position, including timelines for accomplishments, and the expectation for application for further fellowship or advanced career development awards. Significant new resources have been obtained for the pulmonary research environment at both the University of Colorado Denver and its affiliated institute. National Jewish Health. The proposed research training is three years, four positions each in post graduate years 5, 6, 7. We maintain our goal of preparing the next generation of pulmonary investigators.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007085-40
Application #
8692998
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
40
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Aurora
State
CO
Country
United States
Zip Code
80045
Janssen, William J; Stefanski, Adrianne L; Bochner, Bruce S et al. (2016) Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions. Eur Respir J 48:1201-1214
Mathai, Susan K; Pedersen, Brent S; Smith, Keith et al. (2016) Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 193:1151-60
Honda, Jennifer R; Bernhard, Jon N; Chan, Edward D (2015) Natural disasters and nontuberculous mycobacteria: a recipe for increased disease? Chest 147:304-8
Honda, Jennifer R; Hess, Tamara; Malcolm, Kenneth C et al. (2015) Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids. PLoS One 10:e0126994
Biehl, Jason R; Burnham, Ellen L (2015) Cannabis Smoking in 2015: A Concern for Lung Health? Chest 148:596-606
Mathai, Susan K; Schwartz, David A (2015) Taking the "I" out of IPF. Eur Respir J 45:1539-41
Yunt, Zulma X; Mohning, Michael P; Barthel, Lea et al. (2014) Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin. Exp Lung Res 40:415-25
Honda, Jennifer R; Connick, Elizabeth; MaWhinney, Samantha et al. (2014) Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy. J Med Microbiol 63:997-1003
Mathai, Susan K; Schwartz, David A; Warg, Laura A (2014) Genetic susceptibility and pulmonary fibrosis. Curr Opin Pulm Med 20:429-35
Clark, Brendan J; Bull, Todd M; Benson, Alexander B et al. (2013) Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Crit Care 17:R92

Showing the most recent 10 out of 67 publications